Health Condition 1: J309- Allergic rhinitis, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Subjects diagnosed as allergic rhinitis based on reported symptoms. Subjects will have a total nasal symptom score (TNSS) of more than equal to 3. Subjects must provide informed consent to participate in the study.
Exclusion criteria
Exclusion criteria: Subjects with a history of asthma (other than mild intermittent) and taking asthma medications or nasal disorders (such as deviated septum nasal polyposis or chronic rhinosinusitis) acute or significant sinusitis and those with an existing serious medical condition (eg severe emphysema). Subjects receiving allergen immunotherapy acute or chronic infections or on prolonged (more than equal to 6 weeks) medication with corticosteroids anticholinergics or any other drugs that may have an influence on the outcome of the study. Pregnant or lactating individuals due to potential risks to the fetus or infant from Ayurvedic treatments.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Assessing the mean change in Total Nasal Symptom Score (TNSS)Timepoint: baseline to Day 14 and Day 28. | — |
Secondary
| Measure | Time frame |
|---|---|
| Assessment of the total RQLQ scoreTimepoint: baseline to Day 14 and Day 28.;Assessing domain-wise changes in RQLQ scores to determine the impact on specific aspects of quality of life.Timepoint: baseline to Day 14 and Day 28.;Assessing the percentage of symptom-free days relative to the total number of days during the study periodTimepoint: baseline to Day 14 and Day 28. | — |
Countries
India
Contacts
Patanjali Yoggram Yog Naturopathy Panchkarma Treatment and Research Centre